360 related articles for article (PubMed ID: 35609926)
1. Extrachromosomal DNA in Cancer.
Bafna V; Mischel PS
Annu Rev Genomics Hum Genet; 2022 Aug; 23():29-52. PubMed ID: 35609926
[TBL] [Abstract][Full Text] [Related]
2. Extrachromosomal DNA: An Emerging Hallmark in Human Cancer.
Wu S; Bafna V; Chang HY; Mischel PS
Annu Rev Pathol; 2022 Jan; 17():367-386. PubMed ID: 34752712
[TBL] [Abstract][Full Text] [Related]
3. Extrachromosomal DNA amplifications in cancer.
Yi E; Chamorro González R; Henssen AG; Verhaak RGW
Nat Rev Genet; 2022 Dec; 23(12):760-771. PubMed ID: 35953594
[TBL] [Abstract][Full Text] [Related]
4. Extrachromosomal DNA (ecDNA) in cancer pathogenesis.
Wu S; Bafna V; Mischel PS
Curr Opin Genet Dev; 2021 Feb; 66():78-82. PubMed ID: 33477016
[TBL] [Abstract][Full Text] [Related]
5. Progress on the role of extrachromosomal DNA in tumor pathogenesis and evolution.
Xing J; Ning Q; Tang D; Mo Z; Lei X; Tang S
Clin Genet; 2021 Apr; 99(4):503-512. PubMed ID: 33314031
[TBL] [Abstract][Full Text] [Related]
6. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers.
Kim H; Nguyen NP; Turner K; Wu S; Gujar AD; Luebeck J; Liu J; Deshpande V; Rajkumar U; Namburi S; Amin SB; Yi E; Menghi F; Schulte JH; Henssen AG; Chang HY; Beck CR; Mischel PS; Bafna V; Verhaak RGW
Nat Genet; 2020 Sep; 52(9):891-897. PubMed ID: 32807987
[TBL] [Abstract][Full Text] [Related]
7. Breaking the vicious circle: Extrachromosomal circular DNA as an emerging player in tumour evolution.
Robert M; Crasta K
Semin Cell Dev Biol; 2022 Mar; 123():140-150. PubMed ID: 34857471
[TBL] [Abstract][Full Text] [Related]
8. ATACAmp: a tool for detecting ecDNA/HSRs from bulk and single-cell ATAC-seq data.
Cheng H; Ma W; Wang K; Chu H; Bao G; Liao Y; Yuan Y; Gou Y; Dong L; Yang J; Cai H
BMC Genomics; 2023 Nov; 24(1):678. PubMed ID: 37950200
[TBL] [Abstract][Full Text] [Related]
9. Extrachromosomal DNA in cancer.
Yan X; Mischel P; Chang H
Nat Rev Cancer; 2024 Apr; 24(4):261-273. PubMed ID: 38409389
[TBL] [Abstract][Full Text] [Related]
10. Gene regulation on extrachromosomal DNA.
Hung KL; Mischel PS; Chang HY
Nat Struct Mol Biol; 2022 Aug; 29(8):736-744. PubMed ID: 35948767
[TBL] [Abstract][Full Text] [Related]
11. The evolutionary dynamics of extrachromosomal DNA in human cancers.
Lange JT; Rose JC; Chen CY; Pichugin Y; Xie L; Tang J; Hung KL; Yost KE; Shi Q; Erb ML; Rajkumar U; Wu S; Taschner-Mandl S; Bernkopf M; Swanton C; Liu Z; Huang W; Chang HY; Bafna V; Henssen AG; Werner B; Mischel PS
Nat Genet; 2022 Oct; 54(10):1527-1533. PubMed ID: 36123406
[TBL] [Abstract][Full Text] [Related]
12. The genomic and spatial mobility of extrachromosomal DNA and its implications for cancer therapy.
van Leen E; Brückner L; Henssen AG
Nat Genet; 2022 Feb; 54(2):107-114. PubMed ID: 35145302
[TBL] [Abstract][Full Text] [Related]
13. Pioneering insights of extrachromosomal DNA (ecDNA) generation, action and its implications for cancer therapy.
Li Z; Wang B; Liang H; Han L
Int J Biol Sci; 2022; 18(10):4006-4025. PubMed ID: 35844796
[TBL] [Abstract][Full Text] [Related]
14. Live-Cell Imaging Shows Uneven Segregation of Extrachromosomal DNA Elements and Transcriptionally Active Extrachromosomal DNA Hubs in Cancer.
Yi E; Gujar AD; Guthrie M; Kim H; Zhao D; Johnson KC; Amin SB; Costa ML; Yu Q; Das S; Jillette N; Clow PA; Cheng AW; Verhaak RGW
Cancer Discov; 2022 Feb; 12(2):468-483. PubMed ID: 34819316
[TBL] [Abstract][Full Text] [Related]
15. Guilt by association: EcDNA as a mobile transactivator in cancer.
Zhu Y; Gong L; Wei CL
Trends Cancer; 2022 Sep; 8(9):747-758. PubMed ID: 35753910
[TBL] [Abstract][Full Text] [Related]
16. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity.
Turner KM; Deshpande V; Beyter D; Koga T; Rusert J; Lee C; Li B; Arden K; Ren B; Nathanson DA; Kornblum HI; Taylor MD; Kaushal S; Cavenee WK; Wechsler-Reya R; Furnari FB; Vandenberg SR; Rao PN; Wahl GM; Bafna V; Mischel PS
Nature; 2017 Mar; 543(7643):122-125. PubMed ID: 28178237
[TBL] [Abstract][Full Text] [Related]
17. Insight on ecDNA-mediated tumorigenesis and drug resistance.
Huang Q; Zhang S; Wang G; Han J
Heliyon; 2024 Mar; 10(6):e27733. PubMed ID: 38545177
[TBL] [Abstract][Full Text] [Related]
18. Extrachromosomal DNA (ecDNA): an origin of tumor heterogeneity, genomic remodeling, and drug resistance.
Pecorino LT; Verhaak RGW; Henssen A; Mischel PS
Biochem Soc Trans; 2022 Dec; 50(6):1911-1920. PubMed ID: 36355400
[TBL] [Abstract][Full Text] [Related]
19. Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.
Chapman OS; Luebeck J; Sridhar S; Wong IT; Dixit D; Wang S; Prasad G; Rajkumar U; Pagadala MS; Larson JD; He BJ; Hung KL; Lange JT; Dehkordi SR; Chandran S; Adam M; Morgan L; Wani S; Tiwari A; Guccione C; Lin Y; Dutta A; Lo YY; Juarez E; Robinson JT; Korshunov A; Michaels JA; Cho YJ; Malicki DM; Coufal NG; Levy ML; Hobbs C; Scheuermann RH; Crawford JR; Pomeroy SL; Rich JN; Zhang X; Chang HY; Dixon JR; Bagchi A; Deshpande AJ; Carter H; Fraenkel E; Mischel PS; Wechsler-Reya RJ; Bafna V; Mesirov JP; Chavez L
Nat Genet; 2023 Dec; 55(12):2189-2199. PubMed ID: 37945900
[TBL] [Abstract][Full Text] [Related]
20. Oncogene expression from extrachromosomal DNA is driven by copy number amplification and does not require spatial clustering in glioblastoma stem cells.
Purshouse K; Friman ET; Boyle S; Dewari PS; Grant V; Hamdan A; Morrison GM; Brennan PM; Beentjes SV; Pollard SM; Bickmore WA
Elife; 2022 Dec; 11():. PubMed ID: 36476408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
